search
Back to results

Adolescent Coordinated Transition Nigerian HIV+ Youth (ACT)

Primary Purpose

HIV/AIDS

Status
Unknown status
Phase
Not Applicable
Locations
Nigeria
Study Type
Interventional
Intervention
ACT
Sponsored by
University of Nevada, Las Vegas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for HIV/AIDS focused on measuring Healthcare transition, Adolescents, Nigeria

Eligibility Criteria

13 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Documented HIV infection
  • Aware of HIV diagnosis
  • Currently on ART

Exclusion Criteria:

  • Medically unstable

Sites / Locations

  • Institute of Human VirologyRecruiting
  • Center for Integrated Health ProgramRecruiting
  • Centre for Clinical Care and ResearchRecruiting
  • Family Health InternationalRecruiting
  • AIDS Prevention Initiative NigeriaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

ACT Intervention

Arm Description

The control arm does not receive the ACT intervention.

Intervention activities include the three components of the ACT intervention: (1) alternating pediatric and adult clinic visits in the 12 month pre-transfer period (2) peer facilitated organized support group during the 24-month graduated transition period and (3) patient advocate and case management team to coordinate transfer process.

Outcomes

Primary Outcome Measures

Retention in care in care 6 months post-transfer
Proportion of participants who had at least 1 clinical visit to an HIV provider within the 6 months post-transfer
Retention in care 12 months post-transfer
Proportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within the 1 year period post-transfer
Retention in care 24 months post-transfer
Proportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within a 1 year period during the second year post-transfer

Secondary Outcome Measures

Viral Suppression
Proportion of participants with undetectable viral load
Mental Health and Wellbeing
Mental health continuum-short form Questionnaire
Health Locus of Control
Health Locus of control / Self-esteem Questionnaire
Social Support
Functional Social Support Questionnaire
Sexual Risk Behavior
Sexual Risk Beliefs and Behavior Self Efficacy Questionnaire
Transition Readiness
Transition Readiness Assessment Questionnaire

Full Information

First Posted
May 9, 2017
Last Updated
October 14, 2017
Sponsor
University of Nevada, Las Vegas
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT03152006
Brief Title
Adolescent Coordinated Transition Nigerian HIV+ Youth
Acronym
ACT
Official Title
Adolescent Coordinated Transition (ACT) to Improve Health Outcomes Among Nigerian HIV+ Youth
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Unknown status
Study Start Date
June 28, 2017 (Actual)
Primary Completion Date
May 30, 2020 (Anticipated)
Study Completion Date
June 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Nevada, Las Vegas
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the comparative effectiveness of a comprehensive, coordinated transition protocol which includes an early introduction to the adult provider, an integrated case management team and a peer-facilitated organized support group on retention in care, viral suppression and psychosocial wellbeing among adolescents living with HIV.
Detailed Description
Using a two-arm cluster randomized design, our proposed study will evaluate the comparative effectiveness of ACT, a coordinated protocol for transitioning adolescents living with HIV (ALHIV) from pediatric to adult care (Intervention Group; IG) versus the usual abrupt transfer to adult care (Control group; CG) on rates of retention in care and viral suppression, and differences in perceived psychosocial wellbeing. Twelve health facilities, two in each of the six geopolitical zones of Nigeria will be pair-matched and randomly assigned to either IG (N=6 health facilities) or CG (N=6 health facilities). A total of 216 ALHIV will be enrolled in the study over a 36-month period. The primary outcome will be the difference in the rate of retention between the groups. Secondary outcomes will be difference in the rate of viral suppression and the difference in perceived psychosocial wellbeing. Additionally, the investigators will conduct mediation/moderation analysis to examine the role of intermediate variables such as transition readiness, perceived mental health, social support, health locus of control, self-esteem and sexual risk behavior self-efficacy on the primary outcomes. Implementation factors will be assessed using the hybrid 2 model.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
Healthcare transition, Adolescents, Nigeria

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
216 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
The control arm does not receive the ACT intervention.
Arm Title
ACT Intervention
Arm Type
Experimental
Arm Description
Intervention activities include the three components of the ACT intervention: (1) alternating pediatric and adult clinic visits in the 12 month pre-transfer period (2) peer facilitated organized support group during the 24-month graduated transition period and (3) patient advocate and case management team to coordinate transfer process.
Intervention Type
Other
Intervention Name(s)
ACT
Intervention Description
Coordinated, graduated transition which includes an early introduction to the adult clinician during the PAPA pre-transfer period, a peer-facilitated organized support group aimed at improving transition readiness and addressing critical psychosocial skills including self-efficacy and locus of control and a case management team including a patient advocate who coordinates the transfer between pediatric and adult care teams.
Primary Outcome Measure Information:
Title
Retention in care in care 6 months post-transfer
Description
Proportion of participants who had at least 1 clinical visit to an HIV provider within the 6 months post-transfer
Time Frame
6 months
Title
Retention in care 12 months post-transfer
Description
Proportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within the 1 year period post-transfer
Time Frame
12 months
Title
Retention in care 24 months post-transfer
Description
Proportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within a 1 year period during the second year post-transfer
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Viral Suppression
Description
Proportion of participants with undetectable viral load
Time Frame
Enrollment, baseline (12 months), 24 and 36 months
Title
Mental Health and Wellbeing
Description
Mental health continuum-short form Questionnaire
Time Frame
Enrollment, baseline (12 months), 24 and 36 months
Title
Health Locus of Control
Description
Health Locus of control / Self-esteem Questionnaire
Time Frame
Enrollment, baseline (12 months), 24 and 36 months
Title
Social Support
Description
Functional Social Support Questionnaire
Time Frame
Enrollment, baseline (12 months), 24 and 36 months
Title
Sexual Risk Behavior
Description
Sexual Risk Beliefs and Behavior Self Efficacy Questionnaire
Time Frame
Enrollment, baseline (12 months), 24 and 36 months
Title
Transition Readiness
Description
Transition Readiness Assessment Questionnaire
Time Frame
Enrollment, baseline (12 months), 24 and 36 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Documented HIV infection Aware of HIV diagnosis Currently on ART Exclusion Criteria: Medically unstable
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Echezona Ezeanolue, MD, MPH
Phone
702-895-2687
Email
echezona.ezeanolue@unlv.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Nadia Sam-Agudu, MD
Phone
+2347063501205
Email
nsamagudu@ihvnigeria.org
Facility Information:
Facility Name
Institute of Human Virology
City
Abuja
State/Province
FCT
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nadia Sam-Agudu
Facility Name
Center for Integrated Health Program
City
Abuja
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bolanle Oyeledu, MD
Facility Name
Centre for Clinical Care and Research
City
Abuja
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ayodotun Olutola, MD
Facility Name
Family Health International
City
Abuja
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hadiza Khamofu, MD
Facility Name
AIDS Prevention Initiative Nigeria
City
Lagos
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Prosper Okonkwo

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29237487
Citation
Sam-Agudu NA, Pharr JR, Bruno T, Cross CL, Cornelius LJ, Okonkwo P, Oyeledun B, Khamofu H, Olutola A, Erekaha S, Menson WNA, Ezeanolue EE. Adolescent Coordinated Transition (ACT) to improve health outcomes among young people living with HIV in Nigeria: study protocol for a randomized controlled trial. Trials. 2017 Dec 14;18(1):595. doi: 10.1186/s13063-017-2347-z. Erratum In: Trials. 2018 Feb 13;19(1):104.
Results Reference
derived

Learn more about this trial

Adolescent Coordinated Transition Nigerian HIV+ Youth

We'll reach out to this number within 24 hrs